Showing results (31-40 of 302) with videos related to
Sort By:
Pageof 31
Alzheimer'S Research & Therapy|July 18, 2014
Truncated and modified amyloid-beta speciesMarkus P Kummer, Michael T HenekaMethods in Molecular Biology (Clifton, N.J.)|July 2, 2013
Studying M1 and M2 states in adult microgliaSadanand M Gaikwad, Michael T HenekaLancet (London, England)|November 16, 2024
Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challengesMichael T Heneka, David Morgan, Frank JessenNature Metabolism|April 10, 2025
Incretin-based therapeutics for the treatment of neurodegenerative diseasesAnika Vear, Michael T Heneka, Christoffer ClemmensenTrends in Immunology|September 21, 2024
The putative contribution of cellular senescence to driving tauopathiesDeniz Karabag, Michael T Heneka, Christina IsingAnnual Review of Immunology|February 29, 2024
Immune Activation in Alzheimer DiseaseArnaud Mary, Renzo Mancuso, Michael T HenekaInternational Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 14, 2006
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanismsMagdalena Sastre, Thomas Klockgether, Michael T HenekaAnnals of Neurology|May 15, 2015
Effect of pioglitazone medication on the incidence of dementiaMichael T Heneka, Anne Fink, Gabriele DoblhammerPPAR Research|August 30, 2008
Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS TumorsLars Tatenhorst, Eric Hahnen, Michael T HenekaPageof 31